Orion OyjORINF +4.81%99 PE Ratio (TTM) is 18.87 as of Jul. 01, 2026, which is 19% below its 10-year median of 23.42. GuruFocus rates ORINF with a GF Score™ of 99/100 and a GF Value™ of $80.82. The stock has 3 warning signs investors should review. Among 636 Drug Manufacturers companies, Orion Oyj ranks better than 53.46% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-01), Orion Oyj's share price is
$82.75.
Orion Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.39. Therefore, Orion Oyj's PE Ratio (TTM) for today is 18.87.
Good Sign:
Orion Oyj stock PE Ratio (=19.07) is close to 2-year low of 17.67.
The historical rank and industry rank for Orion Oyj's PE Ratio (TTM) or its related term are showing as below:
ORINF'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 10.35 Med: 23.42 Max: 33.81
Current: 19.07
During the past 13 years, the highest PE Ratio (TTM) of Orion Oyj was 33.81. The lowest was 10.35. And the median was 23.42.
ORINF's PE Ratio (TTM) is ranked better than 53.46% of 636
companies
in the Drug Manufacturers industry
Industry Median: 20.675
vs ORINF: 19.07
As of today (2026-07-01), Orion Oyj's share price is $82.75.
Orion Oyj's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $4.39. Therefore, Orion Oyj's PE Ratio without NRI for today is 18.87.
During the past 13 years, Orion Oyj's highestPE Ratio without NRI was 33.81. The lowest was 15.76. And the median was 23.61.
Orion Oyj's EPS without NRI for the
three
months ended in Mar. 2026 was $0.74.
Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $4.39.
During the past 12 months, Orion Oyj's average EPS without NRIGrowth Rate was 52.20% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 12.70% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 16.20% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 6.40% per year.
During the past 13 years, Orion Oyj's highest 3-Year average EPS without NRI Growth Rate was 445.40% per year. The lowest was -76.70% per year. And the median was 2.60% per year.
Orion Oyj's EPS (Basic) for the
three
months ended in Mar. 2026 was $0.74.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $4.39.
Orion Oyj (OTCPK:ORINF) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Orion Oyj PE Ratio (TTM) Related Terms
Orion Oyj PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Orion Oyj's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ORINF vs LLY, JNJ, ABBV: PE Ratio (TTM) Comparison
For the Drug Manufacturers - General subindustry, Orion Oyj's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orion Oyj PE Ratio (TTM) vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Orion Oyj's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Orion Oyj's PE Ratio (TTM) for today is calculated as
Orion Oyj's Share Price of today is $82.75.
Orion Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.39.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Orion Oyj (ORINF) has a PE Ratio (TTM) of 18.87 as of Jul. 01, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Orion Oyj and its competitors. This is 19% below median its historical median of 23.42. Over the past decade, Orion Oyj's PE Ratio (TTM) has ranged from 10.35 to 33.81. According to the industry distribution chart, Orion Oyj ranks #296 out of 636 companies in the Drug Manufacturers industry, placing it in the top 46.5%.
Is Orion Oyj's PE Ratio (TTM) too high?
Orion Oyj's current PE Ratio (TTM) of 18.87 is 19% below median its 10-year median of 23.42. Over the past 10 years, this metric has ranged from a low of 10.35 to a high of 33.81. The Drug Manufacturers industry median PE Ratio (TTM) is 20.68. Orion Oyj's value of 18.87 is 8.7% below this industry median. Based on the distribution chart, Orion Oyj ranks #296 out of 636 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Orion Oyj has a GF Score™ of 99/100, reflecting its overall financial health beyond just this single metric.
How does Orion Oyj's PE Ratio (TTM) compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Orion Oyj ranks #296 out of 636 companies for PE Ratio (TTM). This puts Orion Oyj in the upper half of its industry. The industry median PE Ratio (TTM) is 20.68. Orion Oyj's value of 18.87 is 8.7% below this benchmark. Historically, Orion Oyj's own PE Ratio (TTM) has ranged from 10.35 to 33.81 over the past decade. While the company's 10-year median is 23.42 vs. the industry median of 20.68, Orion Oyj has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Drug Manufacturers company?
The median PE Ratio (TTM) among Drug Manufacturers companies is 20.68, based on 636 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orion Oyj's current PE Ratio (TTM) of 18.87 is 8.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Orion Oyj and its competitors. For the Drug Manufacturers industry, the median PE Ratio (TTM) is 20.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orion Oyj's current PE Ratio (TTM) is 18.87, which is 19% below median its own 10-year median of 23.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orion Oyj stock overvalued right now?
Orion Oyj (ORINF) has a current PE Ratio (TTM) of 18.87. The stock's GF Value™ is $80.82, compared to a current price of $82.75 — trading 2.4% above its estimated fair value. The current PE Ratio (TTM) is 18.87, which is 19% below median its 10-year median of 23.42 and 8.7% below the Drug Manufacturers industry median of 20.68. Orion Oyj's overall GF Score™ is 99/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Orion Oyj (ORINF), the current PE Ratio (TTM) is 18.87 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Orion Oyj (ORINF) Overvalued in 2026?
Based on GuruFocus' analysis, Orion Oyj stock appears to be overvalued.
The current stock price of $82.75 is trading 2.4% above its estimated GF Value™ of $80.82.
Key valuation signals for ORINF:
PE Ratio (TTM): 18.87 (19% below median its 10-year median of 23.42)
GF Value™: $80.82 vs. price of $82.75 (2.4% above fair value)
Industry Position: 8.7% below the Drug Manufacturers median (#296 of 636)
No single metric tells the full story. See the ORINF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. The company mainly serves Finland but also has a presence in other European countries, North America and other countries.
99GF Score
Get the complete analysis for ORINF
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ORINF has been successfully added to your 
